-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of the cost of borrowed funds accounted for as interest expense.
-
Summary
-
Aquestive Therapeutics, Inc. quarterly/annual Interest Expense history and growth rate from 2017 to 2023.
- Aquestive Therapeutics, Inc. Interest Expense for the quarter ending June 30, 2024 was $2.78M, a 102% increase year-over-year.
- Aquestive Therapeutics, Inc. Interest Expense for the twelve months ending June 30, 2024 was $9.09M, a 48.9% increase year-over-year.
- Aquestive Therapeutics, Inc. annual Interest Expense for 2023 was $6.34M, a 3.28% decline from 2022.
- Aquestive Therapeutics, Inc. annual Interest Expense for 2022 was $6.55M, a 34.8% decline from 2021.
- Aquestive Therapeutics, Inc. annual Interest Expense for 2021 was $10M, a 9.17% decline from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Growth (%)